These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

428 related articles for article (PubMed ID: 22191583)

  • 1. Has nanotechnology led to improved therapeutic outcomes?
    Bosselmann S; Williams RO
    Drug Dev Ind Pharm; 2012 Feb; 38(2):158-70. PubMed ID: 22191583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Micro- and nanoparticles--medical applications.
    Jătariu A; Peptu C; Popa M; Indrei A
    Rev Med Chir Soc Med Nat Iasi; 2009; 113(4):1160-9. PubMed ID: 20191893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanoparticles for direct nose-to-brain delivery of drugs.
    Mistry A; Stolnik S; Illum L
    Int J Pharm; 2009 Sep; 379(1):146-57. PubMed ID: 19555750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The influence of pulmonary surfactant on nanoparticulate drug delivery systems.
    Schleh C; Rothen-Rutishauser B; Kreyling WG
    Eur J Pharm Biopharm; 2011 Apr; 77(3):350-2. PubMed ID: 21195761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The rise and rise of drug delivery.
    Rosen H; Abribat T
    Nat Rev Drug Discov; 2005 May; 4(5):381-5. PubMed ID: 15864267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanoparticulate delivery systems for antiviral drugs.
    Lembo D; Cavalli R
    Antivir Chem Chemother; 2010; 21(2):53-70. PubMed ID: 21107015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances and challenges of nanotechnology-based drug delivery systems.
    Jiang W; Kim BY; Rutka JT; Chan WC
    Expert Opin Drug Deliv; 2007 Nov; 4(6):621-33. PubMed ID: 17970665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Formation, characterization, and fate of inhaled drug nanoparticles.
    Zhang J; Wu L; Chan HK; Watanabe W
    Adv Drug Deliv Rev; 2011 May; 63(6):441-55. PubMed ID: 21118707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unique benefits of nanotechnology to drug delivery and diagnostics.
    McNeil SE
    Methods Mol Biol; 2011; 697():3-8. PubMed ID: 21116949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanotechnology in therapeutics: a focus on nanoparticles as a drug delivery system.
    Bamrungsap S; Zhao Z; Chen T; Wang L; Li C; Fu T; Tan W
    Nanomedicine (Lond); 2012 Aug; 7(8):1253-71. PubMed ID: 22931450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanocarriers.
    Torchilin VP
    Pharm Res; 2007 Dec; 24(12):2333-4. PubMed ID: 17934800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Challenges and solutions for the delivery of biotech drugs--a review of drug nanocrystal technology and lipid nanoparticles.
    Muller RH; Keck CM
    J Biotechnol; 2004 Sep; 113(1-3):151-70. PubMed ID: 15380654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmaceutical development and regulatory considerations for nanoparticles and nanoparticulate drug delivery systems.
    Narang AS; Chang RK; Hussain MA
    J Pharm Sci; 2013 Nov; 102(11):3867-82. PubMed ID: 24037829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanostructure-mediated drug delivery.
    Hughes GA
    Nanomedicine; 2005 Mar; 1(1):22-30. PubMed ID: 17292054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanotechnology in ocular drug delivery.
    Sahoo SK; Dilnawaz F; Krishnakumar S
    Drug Discov Today; 2008 Feb; 13(3-4):144-51. PubMed ID: 18275912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The nanoscale in pulmonary delivery. Part 1: deposition, fate, toxicology and effects.
    Rogueda PG; Traini D
    Expert Opin Drug Deliv; 2007 Nov; 4(6):595-606. PubMed ID: 17970663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances in lipid nanodispersions for parenteral drug delivery and targeting.
    Constantinides PP; Chaubal MV; Shorr R
    Adv Drug Deliv Rev; 2008 Mar; 60(6):757-67. PubMed ID: 18096269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanocrystal technology in the delivery of poorly soluble drugs: an overview.
    Nagarwal RC; Kumar R; Dhanawat M; Das N; Pandit JK
    Curr Drug Deliv; 2011 Jul; 8(4):398-406. PubMed ID: 21453258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug delivery systems: entering the mainstream.
    Allen TM; Cullis PR
    Science; 2004 Mar; 303(5665):1818-22. PubMed ID: 15031496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug nanoparticles: formulating poorly water-soluble compounds.
    Merisko-Liversidge EM; Liversidge GG
    Toxicol Pathol; 2008 Jan; 36(1):43-8. PubMed ID: 18337220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.